UK national guidelines on HIV testing 2006

International Journal of STD and AIDS

Volumn 17, Issue 10, 2006, Pages 668-676

  Rogstad, Karen E ^a   Palfreeman, Adrian ^g   Rooney, Guy ^h   Hart, Graham J ^c   Lowbury, Ruth ^e   Mortimer, Philip ^f   Carter, Peter ^b   Jarrett, Sandra ^d   Stewart, Ewen ⁱ   Summerside, Jack ^j  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL LONDON HOSPITAL   (United Kingdom)

^e Medical Foundation for HIV and Sexual Health (MedFASH)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^h GREAT WESTERN HOSPITAL   (United Kingdom)

ⁱ Rose Garden Medical Centre   (United Kingdom)

^j TERRENCE HIGGINS TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CLINICAL FEATURE; CONSULTATION; GENERAL PRACTICE; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; LABORATORY TEST; OCCUPATIONAL EXPOSURE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVACY; REVIEW; RISK FACTOR; SCREENING TEST; UNITED KINGDOM; VIRUS EXAMINATION;

AMBULATORY CARE FACILITIES; CONFIDENTIALITY; COUNSELING; GREAT BRITAIN; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INSURANCE COVERAGE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINES; RNA, VIRAL;

EID: 33750278781     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206780071045     Document Type: Review

References (31)

1. The UK Collaborative group for HIV and STI Surveillance. Mapping the Issues. HIV and Other Sexually Transmitted Infections in the UK in 2005. London: Health Protection Agency Centre for Infections, 2005
2. The national strategy for sexual health and HIV, July 2001 [www.doh.gov.uk]
3. Thomas A, Forster G, Robinson A, Rogstad K. National guideline for the management of suspected sexually transmitted infections in children and young people. Arch Dis Child 2003;88:303-11
4. Rogstad K, Palfreeman A. HIV testing for patients attending general medical services: concise guidelines. Clin Med 2004;4:136-9
5. US Department of Health and Human Services Agency for Healthcare Policy and Research [www.ahrq.gov]
6. British HIV Association (BHIVA). Guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med 2003;4(Suppl 1):1-41
7. Munday P, Mullan H. Encouraging HIV testing in GUM clinics - can we dispense with the pre-test discussion? Int J STD AIDS 1999;10:728-9
8. Busch MP, Statten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102:117-24
9. Pinto LA, Landay AL, Berzofsky JA, Kessler HA, Shearer GM. Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood. Am J Med 1997;102:21-4
10. Lindback S, Thorstensson R, Karlsson AC, et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000;14:2333-9
11. Phair JP, Margolick JB, Jacobson LP, et al. Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outcome. J Infect Dis 1997;175:959-62
12. Groopman JE, Caiazzo T, Thomas MA, et al. Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion. Blood 1988;71:1752-4
13. Henrard DR. Virological and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:305-10
14. Ciesielski CA, Metler RP. Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus. Am J Med 1997;102:115-16
15. Smit EJ, Screening guidelines for sexually transmitted Infections: Human Immunodeficiency Virus (HIV) [www.BASHH.org.uk]
16. Parry JV, Mortimer PP, Perry KR, Pillay D, Zuckerman M, for the Health Protection Agency HIV Laboratory Diagnoses Forum. Towards error-free HIV diagnosis: guidelines on laboratory practice. Commun Dis Public Health 2003;6:334-50
17. Brambilla D, Granger S, Jennings C, Bremer J. Rates of false-positive results on quantitative HIV RNA assays. Abstract 236: CROI 2001
18. Gallo D, George JR, Fitchen JH, Goldstein AS, Hindahl MS. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. Orasure Clinical Trials Group. JAMA 1997;227:792
19. Rogstad K, Bramham L, Lowbury R, Kinghorn G. The use of a leaflet to replace verbal pre-test discussion for HIV - effects and acceptability. Sex Transm Infect 2003;79:243-5
20. Serious Communicable Diseases, General Medical Council 1997 [www.gmc-uk.org]
21. HIV post exposure prophylaxis - guidance from the UK Expert Advisory Group on AIDS: UK Health Department. July 2000 [www.doh.gov.uk/eaga:/ publications.htm]
22. ABI statement of best practice on HIV and Insurance: Association of British Insurers. October 2004. [www.abi.org.uk]
23. Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Prescott RJ. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ 1998;316:262-7
24. Read J, Winceslaus SJ. New strategies for increasing the detection of HIV: analysis of routine data. BMJ 2003;326:1066-7
25. Stanley B, Fraser J, Cox N. Uptake of HIV screening in genitourinary medicine after change to opt-out consent. BMJ 2003;326:1174
26. Simpson WM, Johnstone FD, Goldberg DJ, Gormley SM, Hart GJ. Antenatal HIV testing: assessment of a routine voluntary approach. BMJ 1999;318:1660-1
27. Lister P, Thirlby D, Fox E. Identifying HIV risk and increasing HIV testing within routine GUM consultation. MSSVD Spring Conference, Oslo 2002
28. Simpson W, Johnstone FD, Hart GJ, Goldberg DJ, Boyd FM. A comparison of opt-in and opt-out HIV testing in antenatal care: uptake and acceptability in Edinburgh, Scotland. XII International Conference on AIDS, Geneva 1998
29. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ 2003;168:679-82
30. Day S, Lakhani D, Hankins M, Rodgers CA. Improving upatke of HIV testing in patients with a confrimed STI. Int J STD AIDS 2004;15:626-8
31. Kegg S, Natha M, Lau R, Pakianathan M. Communication with patients: are email and Text the answer P147 BASHH/ASTDA Bath 2004. Int J STD AIDS 2004;15(Suppl 1):46